Effect of High Intensity Laser on Hemiplegic Shoulder Dysfunction

Stroke Clinical Trial

Official title:

Effect of High Intensity Laser on Hemiplegic Shoulder Dysfunction Double Blinded, Placebo-controlled Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05595720
• Other study ID #: Deraya U
• Status: Completed
• Phase: Phase 1
• Start date: October 20, 2022
• Est. completion date: January 20, 2023

Study information

• Verified date: September 2023
• Source: Deraya University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Hemiplegic shoulder pain (HSP) is a common and disabling complication following a stroke, and it may affect the quality of life. It often occurs following two to three months of stroke. Upper limb impairment is seen in 90% of patients affected by stroke.

Numerous causes have been implicated in developing HSP in stroke. This includes muscle flaccidity around the shoulder joint, shoulder subluxation, shoulder-hand syndrome, increased muscle tone, impingement syndrome, frozen shoulder, brachial plexus injury, and the thalamic syndrome.

Muscle paresis, abnormal muscle tone and loss of proprioception following stroke may render the shoulder complex unstable and therefore prone to misalignment.

In recent years, high-intensity laser therapy (HILT) has been considered as a treatment option for shoulder pain.

HILT increases microcirculation and tissue regeneration and lowers edema, inflammation, and pain with its photomechanical, thermal, electrical, and bio stimulating effects in deep tissues that cannot be reached with LILT.

It has some advantages over LILT, i.e., having higher power, greater tissue penetration capacity to deep tissues, the short emission time, and long rest periods preventing heat accumulation.

In recent studies, effectiveness of HILT has been shown in the treatment of subacromial impingement syndrome, rotator cuff tendinopathy, and frozen shoulder.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 44
• Est. completion date: January 20, 2023
• Est. primary completion date: January 18, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 40 Years to 75 Years

Eligibility

Inclusion Criteria:

• DISORDER MORE THAN 6 MONTHS

• UNILATERAL

• FIRST TIME

Exclusion Criteria:

• Iinflammatory rheumatic disease,

• cervical radiculopathy,

• diabetes mellitus,

• thyroid disease,

• coronary heart disease,

• cardiac pacemaker,

• neurological disease,

• shoulder surgery, and

• shoulder injection in the last 3 months

Related Conditions & MeSH terms

• Shoulder Dislocation
• Stroke

Intervention

Device:
• hight intenisty laser
7W(LAZR-207)/15W(LAZR-215&115)HIGH POWER LASER THERAPYUNIT WITH 2 WAVELENGTHMODES,COMBINATION(810+980 NM) AND SINGLE(1064 NM)

Locations

Country	Name	City	State
Egypt	Physical Therapy	Minya	??????

Sponsors (1)

Lead Sponsor	Collaborator
Deraya University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	PAIN score	McGill pain questioner scale, scoring from zero to 78 zero is the best score seventy eight is the worst score	1 MONTH
Primary	FUNCTION	UCLA shoulder score from zero to 35 zero is the worst 35 is the best	1 MONTH